CVC sports empire signs EUR 3.5bln debt deal after stake sale falters, FT reports

CVC's debt deal signals a strategic pivot after the failed equity raise, suggesting current market conditions may be challenging for large-scale equity financing.

Newsquawk StaffPublished On the live feed at 3 more headlines followed before this page went public
Newsquawk headlinesUTC

BioNTech (22UA GY / BNTX) FY 2025 (EUR): Revenue 2.87bln (exp. 2.72bln), EPS -4.70 (exp. -3.08); outlook: Revenue 2-2.3bln (exp. 2.75bln)

Medtronic (MDT) to acquire Scientia Vascular for USD 550mln with the acquisition expected to close in H1 '27; acquisition expected to be minimally dilutive to Medtronic adj. EPS in FY27

CVC sports empire signs EUR 3.5bln debt deal after stake sale falters, FT reports

Iran notes an explosion of an oil tanker near Abu Dhabi, according to Iranian Press

UK Court has refused permission for a legal challenge after UK-Mauritius deal on Chagos Islands

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
  • Private equity firm agrees financing with KKR (KKR) and Pimco (ALV GY) after failing to convince investors to commit to large equity deal
Context

The involvement of notable players like KKR and Pimco indicates confidence in the cash flow of CVC's assets but also underscores potential concerns about investor appetite for risk in the current environment. This could affect equity valuations in the broader insurance sector and influence market sentiment around leveraged transactions.

Related headlines

The whole workspace, free to try.

Try it free